Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome Read more
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter Read more
Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients Read more
Innomar Strategies Enhances Commercialization Expertise with Acquisition of Therapeutic Products Read more
Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma Read more
AbbVie Submits Application to EMA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis Read more
Bavarian Nordic receives FDA Orphan Drug Designation for BN-Brachyury for the treatment of Chordoma Read more